Brief: Positive Data From Phase II Trial In Soft Tissue Sarcoma Presented At CTOS 2024 Annual Meeting
14/11/2024 13:19
Nov 14 (Reuters) - Immutep Ltd IMM.AX :
* POSITIVE DATA FROM PHASE II TRIAL IN SOFT TISSUE SARCOMA
PRESENTED AT CTOS 2024 ANNUAL MEETING
Source text: ID:nGNX3l50Gx
Further company coverage: IMM.AX
((Reuters.Briefs@thomsonreuters.com;))